24 August 2015. Professor Christophe Hagemeyer, head of the Vascular Biotechnology Laboratory at Baker IDI Heart and Diabetes Institute in Melbourne, discusses new nanotechnology which can deliver clot-busting drugs right to the clot. With MJA engagement editor Cate Swannell.